Trial updateOphthalmology
To Evaluate the Efficacy and Safety of Combination Therapy With B55R1 and B55R2 Compared to B55R1 Monotherapy in Patients With NPDR
Completed. Phase 4. Registered enrolment: 53. AJU Pharm Co., Ltd.
Why it matters
Track this study through NCT07230184. No results are posted in this registry record.
The study at a glance
- Registry status
- Completed
- Phase
- Phase 4
- Registered enrolment
- 53
- Results posted
- No
- Sponsor
- AJU Pharm Co., Ltd.
Keep in mind
Registry information describes the study; recruitment status alone does not establish efficacy or safety.